Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), and its subsidiary Organigram Inc., a leading licensed producer of cannabis in Canada, has reached a proposed settlement in a class action related to medical cannabis that was voluntarily recalled in December 2016 and January 2017. The Supreme Court of Nova Scotia approved notice of settlement will be sent to class members beginning on June 24, 2022.
As part the settlement, the company has agreed to pay an aggregate of $2.31 million, which amount has been previously accrued in the company’s financial statements for the prior fiscal year.
